These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8381460)

  • 1. The nature and spatial distribution of amino acid substitutions conferring resistance to neutralizing monoclonal antibodies in human rhinovirus type 2.
    Speller SA; Sangar DV; Clarke BE; Rowlands DJ
    J Gen Virol; 1993 Feb; 74 ( Pt 2)():193-200. PubMed ID: 8381460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization epitopes of human rhinovirus type 2.
    Appleyard G; Russell SM; Clarke BE; Speller SA; Trowbridge M; Vadolas J
    J Gen Virol; 1990 Jun; 71 ( Pt 6)():1275-82. PubMed ID: 1693662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14.
    Sherry B; Mosser AG; Colonno RJ; Rueckert RR
    J Virol; 1986 Jan; 57(1):246-57. PubMed ID: 2416951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing antibodies to human rhinovirus produced in laboratory animals and humans that recognize a linear sequence from VP2.
    Hastings GZ; Speller SA; Francis MJ
    J Gen Virol; 1990 Dec; 71 ( Pt 12)():3055-9. PubMed ID: 1703215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to a peptide of human rhinovirus type 2 with different specificities recognize the same minimum sequence.
    Barnett PV; Rowlands DJ; Campbell RO; Parry NR
    J Gen Virol; 1995 May; 76 ( Pt 5)():1255-61. PubMed ID: 7730811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of neutralization epitopes on the VP7 surface protein of serotype G11 porcine rotaviruses.
    Ciarlet M; Hidalgo M; Gorziglia M; Liprandi F
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1867-73. PubMed ID: 7519247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
    Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
    Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD; Barrett AD
    Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a new neutralization epitope on VP7 of human serotype 2 rotavirus and evidence for electropherotype differences caused by single nucleotide substitutions.
    Dunn SJ; Ward RL; McNeal MM; Cross TL; Greenberg HB
    Virology; 1993 Nov; 197(1):397-404. PubMed ID: 7692670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of equine arteritis virus isolates using neutralizing monoclonal antibodies and identification of sequence changes in GL associated with neutralization resistance.
    Glaser AL; de Vries AA; Dubovi EJ
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2223-33. PubMed ID: 7561759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of monoclonal antibodies raised against a synthetic peptide capable of inducing a neutralizing response to human rhinovirus type 2.
    Barnett PV; Rowlands DJ; Parry NR
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1295-302. PubMed ID: 8393073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
    Smith TJ; Chase ES; Schmidt TJ; Olson NH; Baker TS
    Nature; 1996 Sep; 383(6598):350-4. PubMed ID: 8848050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neutralizing epitope on human rhinovirus type 2 includes amino acid residues between 153 and 164 of virus capsid protein VP2.
    Skern T; Neubauer C; Frasel L; Gründler P; Sommergruber W; Zorn M; Kuechler E; Blaas D
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():315-23. PubMed ID: 2434607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralization.
    Minson AC; Hodgman TC; Digard P; Hancock DC; Bell SE; Buckmaster EA
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1001-13. PubMed ID: 2423636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus.
    Giammarioli AM; Mackow ER; Fiore L; Greenberg HB; Ruggeri FM
    Virology; 1996 Nov; 225(1):97-110. PubMed ID: 8918537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of a neutralizing antibody bound bivalently to human rhinovirus 2.
    Hewat EA; Blaas D
    EMBO J; 1996 Apr; 15(7):1515-23. PubMed ID: 8612574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein.
    Balasuriya UB; Patton JF; Rossitto PV; Timoney PJ; McCollum WH; MacLachlan NJ
    Virology; 1997 May; 232(1):114-28. PubMed ID: 9185595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
    Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of a neutralizing antibody bound monovalently to human rhinovirus 2.
    Hewat EA; Marlovits TC; Blaas D
    J Virol; 1998 May; 72(5):4396-402. PubMed ID: 9557730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants.
    Crowther JR; Farias S; Carpenter WC; Samuel AR
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1547-53. PubMed ID: 8393912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.